tenk.fyi

Liminatus Pharma, Inc.

LIMNNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$10.2M

187.8% YoY

EPS

$-0.43

115.0% YoY

Cash

-

FY 2025 · As of 2025-12-31